SOL-GEL TECHN (Germany) Top Insiders
4SG Stock | EUR 0.39 0.04 11.43% |
SOL-GEL TECHN employs about 53 people. The company is managed by 17 executives with a total tenure of roughly 104 years, averaging almost 6.0 years of service per executive, having 3.12 employees per reported executive. Examination of SOL-GEL TECHN's management performance can provide insight into the company performance.
Alon SeriLevy CEO Chief Executive Officer, Co-Founder, Director |
Nissim Bilman President Vice President - Quality |
SOL-GEL |
SOL-GEL TECHN Management Team Effectiveness
The company has return on total asset (ROA) of 0.0471 % which means that it generated a profit of $0.0471 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1101 %, meaning that it generated $0.1101 on every $100 dollars invested by stockholders. SOL-GEL TECHN's management efficiency ratios could be used to measure how well SOL-GEL TECHN manages its routine affairs as well as how well it operates its assets and liabilities.SOL-GEL TECHN Workforce Comparison
SOL GEL TECHN IS 10 is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 76,109. SOL-GEL TECHN adds roughly 53.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16. SOL GEL TECHN Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. SOL GEL TECHN Price Series Summation is a cross summation of SOL-GEL TECHN price series and its benchmark/peer.
SOL-GEL TECHN Notable Stakeholders
A SOL-GEL TECHN stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as SOL-GEL TECHN often face trade-offs trying to please all of them. SOL-GEL TECHN's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting SOL-GEL TECHN's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Alon SeriLevy | Chief Executive Officer, Co-Founder, Director | Profile | |
Nissim Bilman | Vice President - Quality | Profile | |
Ofer Toledano | Vice President - Research & Development | Profile | |
Ofra LevyHacham | Vice President - Clinical and Regulatory Affairs | Profile | |
Gilad Mamlok | Chief Financial Officer | Profile | |
Ran Gottfried | Independent Director | Profile | |
Jerrold Gattegno | Independent Director | Profile | |
Shmuel Zvi | Independent Director | Profile | |
Dubi Zamir | Vice President - Special Projects | Profile | |
Hani Lerman | Director | Profile | |
Itzik Yosef | Vice President - Operations | Profile | |
Yaffa KrindelSieradzki | Independent Director | Profile | |
Itai Arkin | Director | Profile | |
John Vieira | U.S. Head of Commercialization | Profile | |
Karine Neimann | Vice President - Projects and Planning, Chief Chemist | Profile | |
Jonathan Siegel | Independent Director | Profile | |
Moshe Arkin | Chairman of the Board | Profile |
About SOL-GEL TECHN Management Performance
The success or failure of an entity such as SOL GEL TECHN often depends on how effective the management is. SOL-GEL TECHN management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of SOL-GEL management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the SOL-GEL management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company was incorporated in 1997 and is headquartered in Ness Ziona, Israel. SOL GEL operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 65 people.
SOL-GEL TECHN Workforce Analysis
Traditionally, organizations such as SOL-GEL TECHN use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare SOL-GEL TECHN within its industry.SOL-GEL TECHN Manpower Efficiency
Return on SOL-GEL TECHN Manpower
Revenue Per Employee | 464K | |
Revenue Per Executive | 1.4M | |
Net Loss Per Employee | 513.4K | |
Net Loss Per Executive | 1.6M |
Complementary Tools for SOL-GEL Stock analysis
When running SOL-GEL TECHN's price analysis, check to measure SOL-GEL TECHN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SOL-GEL TECHN is operating at the current time. Most of SOL-GEL TECHN's value examination focuses on studying past and present price action to predict the probability of SOL-GEL TECHN's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SOL-GEL TECHN's price. Additionally, you may evaluate how the addition of SOL-GEL TECHN to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Transaction History View history of all your transactions and understand their impact on performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Valuation Check real value of public entities based on technical and fundamental data |